Dupont

©iStock/Pilin_Petunyia

DuPont study highlights HMO’s benefit on infant gut health

By Will Chu

A DuPont-led study outlines 2’-fucosyllactose’s (2’-FL) beneficial effect on the infant gut compared to galacto-oligosaccharides (GOS) and lactose as a team identify the oligosaccharide as a first choice energy source for selected infant microbes.

'We need to make sure that we talk to them eye to eye and not come across as the big global player.'

DuPont nutrition & health chief: We want to work with start-ups

By Shane STARLING

DuPont’s nutrition & health president, Matthias Heinzel, tells NutraIngredients his multi-billion euro division wants to speed product-to-market time and is “totally open” to working with start-ups in open collaboration.

DuPont Nutrition & Health:

Financials

Nutrition profits jump 23% in mixed DuPont Q3 results

By Shane STARLING

DuPont is reaping the benefit of its €5bn 2011 acquisition of Danish probiotics and enzymes giant Danisco, with its nutrition and health division showing 23% profit growth in a “sluggish” world market.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers